ChemicalBook > CAS DataBase List > Daunorubicin hydrochloride

Daunorubicin hydrochloride

Product Name
Daunorubicin hydrochloride
CAS No.
23541-50-6
Chemical Name
Daunorubicin hydrochloride
Synonyms
DAUNORUBICIN HCL;Cerubidine;DAUNOMYCIN HCL;DAUNOMYCIN HYDROCHLORIDE;(8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride;ondena;CS-585;daunoblastin;ndc0082-4155;daunoblastina
CBNumber
CB7113022
Molecular Formula
C27H29NO10.ClH
Formula Weight
563.98
MOL File
23541-50-6.mol
More
Less

Daunorubicin hydrochloride Property

Melting point:
190°C (dec)
alpha 
D20 +248 ±5° (c = 0.05-0.1 in methanol)
storage temp. 
Inert atmosphere,2-8°C
solubility 
Freely soluble in water and in methanol, slightly soluble in alcohol, practically insoluble in acetone.
form 
solid
color 
red to deep red
Water Solubility 
Soluble in water (50 mM)
λmax
477nm(H2O)(lit.)
Sensitive 
Hygroscopic
Merck 
14,2832
BRN 
4229221
Stability:
Stability
InChIKey
GUGHGUXZJWAIAS-SMLRDAARNA-N
SMILES
C1=CC2C(=O)C3=C(O)C4C[C@](C(C)=O)(O)C[C@H](O[C@@H]5O[C@@H](C)[C@@H](O)[C@@H](N)C5)C=4C(O)=C3C(=O)C=2C(OC)=C1.Cl |&1:10,16,18,20,22,24,r|
EPA Substance Registry System
Daunorubicin hydrochloride (23541-50-6)
More
Less

Safety

Hazard Codes 
Xn,Xi
Risk Statements 
22-40-42/43-36/37/38-20/21/22
Safety Statements 
22-36/37-45-37/39-36-26
RIDADR 
UN 2811 6.1/PG 3
WGK Germany 
3
RTECS 
HB7878000
F 
3-10
HazardClass 
6.1(b)
PackingGroup 
III
HS Code 
29419059
Toxicity
LD50 in mice (mg/kg): 26 i.v. (DiMarco, 1969)
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Danger
Hazard statements

H301Toxic if swalloed

H341Suspected of causing genetic defects

H351Suspected of causing cancer

Precautionary statements

P201Obtain special instructions before use.

P202Do not handle until all safety precautions have been read and understood.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P301+P310IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
1164700
Product name
Daunorubicin hydrochloride
Purity
United States Pharmacopeia (USP) Reference Standard
Packaging
200mg
Price
$1340
Updated
2024/03/01
Sigma-Aldrich
Product number
251800
Product name
Daunorubicin, Hydrochloride
Packaging
5mg
Price
$84.3
Updated
2022/05/15
TCI Chemical
Product number
D4532
Product name
Daunorubicin Hydrochloride
Purity
>98.0%(HPLC)(N)
Packaging
20mg
Price
$246
Updated
2024/03/01
TCI Chemical
Product number
D4532
Product name
Daunorubicin Hydrochloride
Purity
>98.0%(HPLC)(N)
Packaging
100mg
Price
$612
Updated
2024/03/01
Alfa Aesar
Product number
J60224
Product name
Daunorubicin hydrochloride
Packaging
10mg
Price
$214
Updated
2024/03/01
More
Less

Daunorubicin hydrochloride Chemical Properties,Usage,Production

Description

Daunorubicin HCl (23541-50-6) is an antitumor antibiotic used in the treatment of acute myeloid leukemias.1?Induces DNA damage by intercalation.2?Induces apoptosis in a variety of cell lines.3?Inhibition of autophagy with chloroquine enhances daunorubicin-induced apoptosis in K562 cells.4?Cell permeable.

Chemical Properties

Dark Red Crystals

Originator

Cerubidine,Rhone-Poulenc Rorer,France

Uses

Anthracycline antibiotic related to the rhodomycins. Antineoplastic

Uses

Antineoplastic;DNA intercaling

Uses

anti-neoplastic LD50 in mice 26 mg/kg

Uses

A DNA intercalator which may suppress acute leukemia proliferation

Definition

ChEBI: Daunorubicin hydrochloride is an anthracycline.

Manufacturing Process

A 170 liter fermentation vessel is charged with:
Corn steep
2.400 kg
Sucrose
3.600 kg
Calcium carbonate
0.900 kg
Ammonium sulphate
0.240 kg
Water
to 100 liters
This culture medium has a pH of 6.15. It is sterilised by passage of steam at 122°C for 40 minutes. After cooling, the volume of the broth is 120 liters and the pH is 7.20. The medium is then seeded with 200 cc of a culture of the strain Streptomyces 31723. The culture is carried out for 27 hours at 26°- 27°C with agitation and aeration with sterile air. It is then suitable for seeding the production culture. The production culture is carried out in an 800 liter formentation vessel charged with the following:
Soya flour 20 kg
Distillers' solubles 2.500 kg
Soya oil 2.500 liters
Soya oil 2.500 liters
Sodium chloride 5 kg
Water to 465 liters
Starch 10 kg
The pH of the medium thus obtained is adjusted to 7.20 with concentrated sodium hydroxide solution (400 cc). The medium is then sterilised by the passage of steam at 122°C for 40 minutes. After cooling, the volume of the broth is 500 liters and the pH is 6.75. It is then seeded with 50 liters of the culture from the 170 liter fermentation vessel. Culture is carried out at 28°C for 67 hours with agitation and aeration with sterile air. The pH of the medium is then 7.40 and the volume of the fermentation culture is 520 liters. The quantitiy of antibiotic present in the medium is 29 μ/cc.
The above fermentation culture (520 liters; activity 29 μ/cc) is placed in a vessel equipped with an agitator and the pH is adjusted to 1.8 with a concentrated solution of oxalic acid. Agitation is carried out for one hour and a filtration adjuvant (20 kg) then added. The mixture is filtered on a filter-press and the filter-cake washed with water (100 liters) acidified to pH 2 with oxalic acid. The filtrate (612 liters) is treated with concentrated sodium hydroxide solution until the pH is 4.5. The filtrate is then passed through a column containing Amberlite IRC 50 in hydrogen form (20 liters; diameter of column 15.2 cm, height of column 200 cm, height of resin at rest in column 110 cm). The filtrate passes through the bed of Amberlite from base to top at a rate of 40 liters/hour. The column is then washed with water (100 liters) at a rate of 50 liters/hour circulating from base to top and then with methanol (containing 10% water; 75 liters) circulating from top to base at a rate of 50 liters/hour. The washings are discarded and the column is then eluted with a solution having the following composition (per liter):
The eluate (100 liters), which contains the major part of the antibiotic, is concentrated under reduced pressure at 35°C to 10 liters. The concentrate is extracted at pH 7.5 with chloroform (2 times 5 liters). The chloroformic extract is adjusted to pH 4 with a solution of acetic acid in chloroform (10:100 by volume) and then concentrated at 30°C under reduced pressure to 100 cc. The antibiotic is precipitated by the addition of hexane (1 liter), separated, washed and dried to give an amorphous red powder (9 g) of activity 1,400 μ/mg.
The crude antibiotic (17.1 g) obtained as above described (activity 1530 μ/mg) is dissolved with stirring in a mixture of methylene chloride (1.5 liters), carbon tetrachloride (0.3 liters) and water (1.8 liters). The pH is then adjusted
9865 RP (500 mg), obtained as above described, is dissolved in normal sulphuric acid (100 cc) and the solution obtained is heated for 20 minutes on a water-bath. After cooling and extracting with ethyl acetate (3 times 200 cc), the organic extract is dried over anhydrous sodium sulphate, filtered and concentrated to a small volume, giving, after filtering, washing and drying, crystals (218.5 mg). These crystals (150 mg) are dissolved in chloroform (3 cc) and benzene (1.5 cc) and the solution obtained is chromatographed on 20 sheets of Arches No. 310 paper impregnated with a solution of acetone containing 20% formamide, and developed for 90 minutes by means of a 2:1 mixture of chloroform and benzene saturatd with formamide. The principal zone of Rf = 0.86 is cut out of each of the 20 sheets and the 20 zones thus cut out are comminuted in a mixer in the presence of methanol. The mixture obtained is filtered, concentrated, and water (10 volumes) added. The precipitate obtained is filtered off, washed and dried under reduced pressure to give crystals (120 mg). These crystals (170 mg) are dissolved in dioxan containing 20% water (15 cc) and water acidified to pH 4 with 0.1 N hydrochloric acid is added dropwise. The crystals formed are filtered off, washed and dried, thus giving the aglycone of 9865 RP (130 mg) in the form of orange-red needles, having a first melting point at 160°C and a second at 225°C-230°C.
Daudorubicin can be prepared by gene ingineering methods also. to 3 by the addition of normal hydrochloric acid (8 cc). After decanting, the aqueous phase is treated with methylene chloride (7 liters) and 0.1 N sodium hydroxide solution (200 cc) to give a pH of 7.5. After decanting, the aqueous phase is again extracted at pH 7.5 with methylene chloride (3.5 liters). The methylene chloride extracts are combined and concentrated to 100 cc. After the addition of hexane (1 liter) to the concentrate, a product precipitates which is filtered off, washed and dried at 30°C under reduced pressure to give the antibiotic 9865 RP (9.15 g) in the form of an amorphous orange-red powder of activity 2180 μ/mg.

brand name

Cerubidine (Bedford); Cerubidine (Sanofi Aventis); Cerubidine (Wyeth).

Therapeutic Function

Antineoplastic

General Description

Daunorubicin is available in 20- and 100-mg vials for reconstitution.The agent is given intravenously for the treatmentof acute nonlymphocytic and lymphocytic leukemia. Otherunlabeled uses include CML and Kaposi sarcoma. In general,its use is more limited than that of doxorubicin.Daunorubicin lacks the hydroxyl groups found at C-14 ofdoxorubicin. This leads to an increase in the amount of thealcohol metabolite daunorubicinol (active) arising as a resultof reduction of the side chain ketone. This, however, doesnot appear to lead to a significant increase in the occurrenceof cardiotoxicity compared with doxorubicin. The mechanismsof resistance and toxicities of daunorubicin are similarto that of doxorubicin; the major difference betweenthe two agents being the spectrum of cancers that they areused treat.
A liposomal form of daunorubicin is also availableknown as DaunoXome. The drug offers the same advantagesas those seen for the liposomal form of doxorubicin.

General Description

Orange-red powder. Thin red needles decomposing at 188-190°C. An anti-cancer drug.

Air & Water Reactions

Water soluble.

Reactivity Profile

Daunorubicin hydrochloride may emit toxic oxides of nitrogen when heated.

Biological Activity

Anticancer agent that is clinically used to treat nonlymphocytic leukaemia. Inhibits RNA and DNA synthesis and causes DNA fragmentation in vivo .

Biochem/physiol Actions

Potent anticancer agent. Inhibits DNA and RNA synthesis as sequence specific ds-DNA intercalating agent.

Pharmacokinetics

Like Doxil (the liposomal formulation of doxorubicin), DaunoXome is indicated for use in AIDS-related Kaposi's sarcoma and is administered IV at a dose of 40 mg/m2 every 2 weeks. The pharmacokinetic profiles of Doxil and DaunoXome are similar.

Clinical Use

Daunorubicin is administered IV at a dose of 45 mg/m2 for the treatment of lymphocytic and nonlymphocytic leukemia.

Metabolism

The 18.5-hour terminal half-life of daunorubicin is approximately half that of doxorubicin, and the terminal half-life of the active daunorubicinol metabolite is 26.7 hours. Excretion is approximately 40% biliary and 25% urinary.

storage

+4°C

References

1) Laurent and Jaffrezou (2001),?Signaling pathways activated by daunorubicin; Blood?98?913 2) Yang et al. (2014), Doxorubicin, DNA torsion, and chromatin dynamics; Biochim.Biophys.Acta, 1845 84 3) Masquelier?et al.?(2004),?Relationship between daunorubicin concentration and apoptosis induction in leukemic cells; Biochem.Pharmacol.?67?1047 4) Han?et al.?(2011),?Autophagy inhibition enhances daunorubicin-induced apoptosis in K562 cells; PLoS One?6?e28491

Daunorubicin hydrochloride Preparation Products And Raw materials

Raw materials

Preparation Products

ZORUBICIN HCL
More
Less

Daunorubicin hydrochloride Suppliers

Americas 1 Belgium 1 Brazil 2 Canada 5 China 360 Europe 4 France 2 Germany 8 India 33 Israel 2 Japan 7 Mexico 1 Poland 1 Spain 2 Switzerland 3 The Netherlands 1 United Arab Emirates 1 United Kingdom 25 United States 62 Global 521
Ark Pharm, Inc.
Tel
847-367-3680
Fax
847-367-3681
Email
sales@arkpharminc.com
Country
United States
ProdList
1670
Advantage
56
Pure Chemistry Scientific Inc.
Tel
001-857-928-2050 or 1-888-588-9418
Fax
001-617-206-9595
Email
sales@chemreagents.com
Country
United States
ProdList
10186
Advantage
62
LGM Pharma
Tel
1-(800)-881-8210
Fax
615-250-9817
Email
inquiries@lgmpharma.com
Country
United States
ProdList
2123
Advantage
70
AdooQ BioScience, LLC
Tel
+1 (866) 930-6790
Fax
+1 (866) 333-9607
Email
info@adooq.com
Country
United States
ProdList
2782
Advantage
58
BOC Sciences
Tel
16314854226
Email
info@bocsci.com
Country
United States
ProdList
9923
Advantage
65
TargetMol Chemicals Inc.
Tel
+1-781-999-5354 +1-00000000000
Email
marketing@targetmol.com
Country
United States
ProdList
32161
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58
Accela ChemBio Inc.
Tel
+1-858-6993322
Fax
(+1)-858-876-1948
Email
info@accelachem.com
Country
United States
ProdList
17777
Advantage
58
Cckinase, Inc.
Tel
+1 (732)236-3202
Email
sales@cckinase.com
Country
United States
ProdList
2738
Advantage
58
BOC Sciences
Tel
+1-631-485-4226
Fax
1-631-614-7828
Email
inquiry@bocsci.com
Country
United States
ProdList
19553
Advantage
58
Alchem Pharmtech,Inc.
Tel
8485655694
Email
sales@alchempharmtech.com
Country
United States
ProdList
63687
Advantage
58
Protheragen-ING
Tel
+16313385890
Email
info@protheragen-ing.com
Country
United States
ProdList
3868
Advantage
58
Aladdin Scientific
Tel
+1-+1(833)-552-7181
Email
sales@aladdinsci.com
Country
United States
ProdList
57505
Advantage
58
Aston Chemical
Tel
13000000000
Email
sales@astonchem.com
Country
United States
ProdList
1634
Advantage
58
Alfa Chemistry
Tel
Email
info@alfa-chemistry.com
Country
United States
ProdList
2344
Advantage
58
ApexBio Technology
Tel
--
Fax
--
Email
sales@apexbt.com
Country
United States
ProdList
6251
Advantage
58
CarboMer, Inc.
Tel
--
Fax
--
Email
sales@carbomer.com
Country
United States
ProdList
4026
Advantage
67
Focus Biomolecules
Tel
--
Fax
--
Email
sales@focusbiomolecules.com
Country
United States
ProdList
1284
Advantage
58
Cayman Chemical Company
Tel
--
Fax
--
Email
cayman@caymanchem.com
Country
United States
ProdList
6213
Advantage
81
eNovation Chemicals LLC
Tel
--
Fax
--
Email
ales@eNovationChem.com
Country
United States
ProdList
1673
Advantage
58
ACIC FINE CHEMICALS INC
Tel
--
Fax
--
Email
sales@acic.com
Country
United States
ProdList
25
Advantage
58
VWR International, LLC.
Tel
--
Fax
--
Email
@sargentwelch.com
Country
United States
ProdList
6262
Advantage
58
Parchem Fine & Specialty Chemicals
Tel
--
Fax
--
Email
info@parchem.com
Country
United States
ProdList
1031
Advantage
58
Selleck Chemicals LLC
Tel
--
Fax
--
Email
sales@selleckchem.com
Country
United States
ProdList
1848
Advantage
58
Teva API, Inc. (TAPI)
Tel
--
Fax
--
Country
United States
ProdList
12
Advantage
58
MilliporeSigma (Sigma-Aldrich Corp.)
Tel
--
Fax
--
Email
@sial.com
Country
United States
ProdList
5414
Advantage
58
Crescent Chemical Company
Tel
--
Fax
--
Email
fran@creschem.com
Country
United States
ProdList
1441
Advantage
58
2A Biotech USA
Tel
--
Fax
--
Email
info@2abiotech.com
Country
United States
ProdList
1785
Advantage
58
OChem Incorporation
Tel
--
Fax
--
Email
sales@ocheminc.com
Country
United States
ProdList
6501
Advantage
60
Pharmax NA Inc.
Tel
--
Fax
--
Email
info@pharmaxus.com
Country
United States
ProdList
127
Advantage
58
Creative Enzymes
Tel
--
Fax
--
Email
info@creative-enzymes.com
Country
United States
ProdList
6057
Advantage
58
MedChemExpress
Tel
--
Fax
--
Email
sales@medchemexpress.com
Country
United States
ProdList
6398
Advantage
58
Riedel-de Haen AG
Tel
--
Fax
--
Country
United States
ProdList
6773
Advantage
87
TCI America
Tel
--
Fax
--
Email
sales@tciamerica.com
Country
United States
ProdList
6909
Advantage
75
Frontier Scientific, Inc.
Tel
--
Fax
--
Email
sales@frontiersci.com
Country
United States
ProdList
6222
Advantage
86
Matrix Scientific
Tel
--
Fax
--
Email
sales@matrixscientific.com
Country
United States
ProdList
6632
Advantage
80
Santa Cruz Biotechnology, Inc.
Tel
--
Fax
--
Email
scbt@scbt.com
Country
United States
ProdList
3597
Advantage
60
Selleck Chemicals LLC
Tel
--
Fax
--
Email
info@selleckchem.com
Country
United States
ProdList
824
Advantage
60
TOKU-E Company
Tel
--
Fax
--
Email
info@toku-e.com
Country
United States
ProdList
320
Advantage
50
Tecoland Corporation
Tel
--
Fax
--
Email
info@tecoland.com
Country
United States
ProdList
275
Advantage
50
CiVentiChem Inc.
Tel
--
Fax
--
Email
sales@cvchem.com
Country
United States
ProdList
50
Advantage
50
3B Scientific Corporation
Tel
--
Fax
--
Email
sales@3bsc.com
Country
United States
ProdList
6962
Advantage
56
AlliChem, LLC
Tel
--
Fax
--
Email
sales@allichemllc.com
Country
United States
ProdList
6516
Advantage
60
Medical Isotopes
Tel
--
Fax
--
Email
stohler@medicalisotopes.com
Country
United States
ProdList
6181
Advantage
68
NetQem
Tel
--
Fax
--
Email
sales@netqem.us
Country
United States
ProdList
1641
Advantage
38
ACIC Fine Chemicals Inc.
Tel
--
Fax
--
Email
sales@acic.com
Country
United States
ProdList
492
Advantage
48
Waterstone Technology, LLC
Tel
--
Fax
--
Email
sales@waterstonetech.com
Country
United States
ProdList
6786
Advantage
30
2A PharmaChem USA
Tel
--
Fax
--
Email
sales@2apharmachem.com
Country
United States
ProdList
6137
Advantage
39
3B Scientific Corporation
Tel
--
Fax
--
Email
sales@3bsc.com
Country
United States
ProdList
6718
Advantage
47
AK Scientific, Inc.
Tel
--
Fax
--
Email
sales@aksci.com
Country
United States
ProdList
6347
Advantage
65
More
Less

View Lastest Price from Daunorubicin hydrochloride manufacturers

WUHAN FORTUNA CHEMICAL CO., LTD
Product
Daunorubicin hydrochloride 23541-50-6
Price
US $0.00/KG
Min. Order
1KG
Purity
99%,USP
Supply Ability
500kg/month
Release date
2021-07-23
Apeloa production Co.,Limited
Product
Daunorubicin HCl 23541-50-6
Price
US $1.00/g
Min. Order
1g
Purity
0.98
Supply Ability
1000
Release date
2024-05-30
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
Product
Daunorubicin Hydrochloride 23541-50-6
Price
US $0.00/g
Min. Order
1g
Purity
More Than 99%
Supply Ability
100kg/Month
Release date
2024-10-11

23541-50-6, Daunorubicin hydrochlorideRelated Search:

Acetyl coenzyme A sodium salt 6-Aminocaproic acid ALTRENOGEST Doxorubicin hydrochloride Doxycycline hyclate Clindamycin hydrochloride Tetrahydro-4H-pyran-4-one ACLARUBICIN HYDROCHLORIDE Acetylacetone SPECTINOMYCIN DIHYDROCHLORIDE Centchroman Tris(hydroxymethyl)aminomethane Epirubicin hydrochloride Spectinomycin dihydrochloride pentahydrate Topotecan hydrochloride Glycine Lincomycin hydrochloride Hydroxydiethylphenamine

  • 5,12-Naphthacenedione,8-acetyl-10-[(3-aMino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-Methoxy-,hydrochloride (1:1), (8S,10S)-
  • daunoblastin
  • daunoblastina
  • daunomycinchlorohydrate
  • ndc0082-4155
  • ondena
  • rp13057hydrochloride
  • rubidomycinhydrochloride
  • LEUKAEMOMYCIN C HYDROCHLORIDE
  • DAUNOMYCINE HCL
  • DAUNOMYCINE HYDROCHLORIDE
  • DAUNOMYCIN HCL
  • DAUNOMYCIN HYDROCHLORIDE
  • DAUNORUBICINE HYDROCHLORIDE
  • DAUNORUBICIN HCL
  • (-)-DAUNORUBICIN HYDROCHLORIDE
  • DAUNORUBICIN HYDROCHLORIDE
  • DAUNORUCIBICINE HYDROCHLORIDE
  • (8S,10S)-8-ACETYL-10-[(3-AMINO-2,3,6-TRIDEOXY-ALPHA-L-LYXO-HEXOPYRANSOYL)OXY]-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-5,12-NAPHTHACENEDIONE HYDROCHLORIDE
  • 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride (1:1), (8S,10S)-
  • Daunorubicin hydrochloride, >=98%
  • Daunorubicin HCI
  • Daunorubicin Hydrochloride 98.9%
  • WP900 HYDROCHLORIDE
  • (8S,10S)-8-Acetyl-10-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy]-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Hydrochloride
  • (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione Hydrochloride
  • 13-Dihydrocarminomyci
  • 5,12-Naphthacenedione, 8-acetyl-10-(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S,10S)-
  • 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S,10S)-
  • DaunorubicinHcl98.5%
  • DaunoMycin, Monohydrochloride
  • Daunomycin Hydrochloride 23541-50-6
  • Daunorubicin (Daunomycin) HCl
  • Daunorubicin hydrochloride, 97%, an inhibits both DNA and RNA synthesis
  • CS-585
  • Daunorubicin hydrochloride, ≥90% (HPLC)
  • Daunorubicin, Hydrochloride - CAS 23541-50-6 - Calbiochem
  • Daunorubicin hydrochloride, 97%, inhibits both DNA and RNA synthesis
  • Daunorubicin Hydrochloride (RP 13057 Hydrochloride)
  • Daunorubicin Hydrochlorid
  • Daunorubicin (Daunomycin) hydrochloride
  • 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S-cis)-
  • Cerubidine
  • Daunomycin, hydrochloride (8CI)
  • DAUNOBLASTINE
  • (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione Hydrochloride
  • 13-Dihydrocarminomycin
  • Daunorubicin hydrochloride(BICINS)
  • DAUNORUBICIN HCL USP
  • (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride
  • Cerubidine (Daunorubicin HCl, RubidoMycin HCl)
  • (8S,10S)-8-Acetyl-10-[(3-aMino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-Methoxy-5,12-naphthacenedione Hydrochloride
  • (8S-cis)-DaunoMycin Hydrochloride
  • Daunorubicin hydrochloride API
  • (8S,10S)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride
  • (8S,10S)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyransoyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedionehydrochloride
  • Daunorubicin Hydrochloride (200 mg)
  • Daunorubcin hydrochloride